77277-62-4

Basic information

• Product Name: N-(benzyloxycarbonyl)-L-valyl-D-isoglutamine t-butyl ester
• Synonyms: N-(benzyloxycarbonyl)-L-valyl-D-isoglutamine t-butyl ester
• CAS NO: 77277-62-4
• Molecular Weight: 435.521
• Mol File: 77277-62-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N-(benzyloxycarbonyl)-L-valyl-D-isoglutamine t-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N-(benzyloxycarbonyl)-L-valyl-D-isoglutamine t-butyl ester(77277-62-4)
• EPA Substance Registry System: N-(benzyloxycarbonyl)-L-valyl-D-isoglutamine t-butyl ester(77277-62-4)

Safety Data

• Hazardous Substances Data: 77277-62-4(Hazardous Substances Data)

Upstream product

• 51644-83-8 N-(benzyloxy)carbonyl-D-glutamic acid 5-tert-butyl ester 
• 1149-26-4 (S)-N-(benzyloxycarbonyl)valine 
• 77340-94-4 tert-butyl (4R)-4-(benzyloxycarbonylamino)-4-carbamoylbutyrate 
• 53666-01-6 N-(benzyloxycarbonyl)-L-valine N-hydroxy-5-norbornene-2,3-dicarboximide ester 

Relevant articles and documents

Synthesis of fluoro-containing muramyl dipeptide analogs

Twelve Fluoro-containing muramyl dipeptide analogs with perfluoroalkyl at C1 of sugar moiety or C-terminal of peptidyl chain were synthesized.

Glucosamine peptide derivatives, their production and use

Novel glucosamine-peptide derivatives of the formula: STR1 wherein m is 0 or 1; n is 0 or an integer of 1 to 9; R is lower alkyl which may be substituted with hydroxyl, or aryl; R1 is hydrogen or acyl having an acyclic hydrocarbon group, the terminal of which may be substituted with a cyclic hydrocarbon group directly, via a carbonyl group or via an oxygen atom; provided that when R1 is hydrogen m is 1; R2 is hydrogen or lower alkyl which may form a ring by connecting its terminal with the α-nitrogen atom when n is 0, or hydrogen when n is an integer of 1 to 9; R3 is hydrogen or lower alkyl; R4 and R5 are each hydrogen or lower alkyl which may be substituted with hydroxyl or benzyloxyl; R6 is hydrogen or lower alkyl; R7 is alkyl which may be substituted with lower alkoxyl or aralkyl; R8 and R9 are each hydrogen, lower alkyl or aralkyl; and (D) and (L) each indicate configurations if their respective carbon atoms are asymmetric; or an acid addition salt thereof, have immunostimulatory activity.